Stock Analysis
Amrize AG (AMRZ) Stock Analysis
Amrize AG (AMRZ) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Amrize AG (AMRZ) currently has an AIQ Score of 51/100, indicating a neutral setup. Momentum is the strongest factor at 74/100. Risk is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
AMRZ at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $41.38 |
| AIQ Score | 51/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Buy |
| Market Cap | $23.7B |
| P/E Ratio (TTM) | 29.12 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $0.87 |
| Revenue (quarter ended 2026-06-30) | $3.49B |
| Dividend Yield (TTM) | 1.48% |
| Beta | -0.03 |
| Volume | 4.5M |
| 52-week range | $35.79-$65.94 |
| RSI 14 | 81.82 |
| 50-Day SMA | $39.79 |
| 200-Day SMA | $50.62 |
| Analyst Price Target | $48.68 |
| Next Earnings | Feb 16, 2027 |
AMRZAmrize AG
Basic Materials / Construction Materials
Low Priority
In Line With Peers
Latest quote
- Momentum74
- Value41
- Quality—
- Risk resilience34
- Sentiment—
AMRZ Stock Analysis Summary
Amrize AG (AMRZ) currently has an AIQ Score of 51/100, indicating a neutral setup. Momentum is the strongest factor at 74/100. Risk resilience is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, AMRZ has AIQ Score of 51/100 with Momentum base of 74/100 and fading Risk resilience at 34/100. Wait for component alignment before adding exposure.
Momentum (74/100) leads while Risk resilience (34/100) lags. This cross-factor spread creates entry timing uncertainty.
Basic Materials · -0.55% stock move · AMRZ classified in Construction Materials.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is AMRZ Bullish or Bearish Right Now?
AMRZ currently has a neutral overall setup. Momentum is the strongest factor at 74/100, while Risk Resilience is weakest at 34/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 74/100.
- - Price is +4.58% above its 50-day SMA.
- - Analyst target implies +17.64% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (32 vs 12).
- - Value is the current constraint at 41/100.
- - Risk Resilience is weak at 34/100.
- - Price is -17.80% below its 200-day SMA.
Current Consensus
AMRZ's Technical Analysis Consensus is currently Buy, with 32 buy, 1 neutral, and 12 sell votes. AMRZ's 14-day RSI is 81.82, which places the stock in an overbought momentum range. AMRZ's beta is -0.03, indicating lower market sensitivity than the broad market.
What Changed in AMRZ?
The largest recent change in AMRZ is Momentum moving up by 14.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the AMRZ Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
AMRZ Decision Framework
Public evidence layers, setup checks, and risk context for Amrize AG.
Amrize AG (AMRZ) Stock Analysis
Amrize AG has an AIQ Score of 51/100 in a Neutral regime. Momentum is strongest at 74/100. Beta is -0.03, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | AMRZ is in a Neutral AIQ regime with score 51/100. |
| Signal Conflict | The primary conflict is that momentum leads at 74/100 while risk lags at 34/100. |
| Factor Evidence | Momentum 74/100 · Value 41/100 · Risk 34/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 74/100.
Momentum is 74/100 and RSI (14) is 81.8.
AMRZ is in a Neutral regime at 51/100.
Risk factor is 34/100 with beta -0.03 and annual volatility 36.82%.
Current conflict: momentum leads at 74/100 while risk lags at 34/100.
AMRZ Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
AMRZ Fundamentals
AMRZ valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
AMRZ Technical Analysis
AMRZ technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
AMRZ Stock Catalysts
Track AMRZ earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
AMRZ Dividend Analysis
AMRZ dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
AMRZ Financial Data
AMRZ revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
AMRZ Risk Analysis
AMRZ volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
AMRZ Stock News
AMRZ stock news, market tone, recent headlines, and catalyst context.
AMRZ vs Misc / Verify Peers
Current peer cohort: AMRZ · AMSF · AMTM · BFC · BGCP. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| AMRZ Current stock | 51/100 | 41/100 | 74/100 | 34/100 | -0.58 | 36.82% | Current |
| AMSF AMERITAS Life Partners ⚠️ | 49/100 | 57/100 | 33/100 | 38/100 | -1.72 | 31.03% | AMRZ vs AMSF |
| AMTM Anterix ⚠️ | 55/100 | 74/100 | 73/100 | 44/100 | 0.2 | 46.83% | AMRZ vs AMTM |
| BFC Bank First ⚠️ | 56/100 | 33/100 | 72/100 | 48/100 | 0.78 | 23.30% | AMRZ vs BFC |
| BGCP BGC Partners ⚠️ | 45/100 | 38/100 | — | 41/100 | — | — | AMRZ vs BGCP |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching AMRZ
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for AMRZ
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
AMRZ Stock FAQ
What is AMRZ stock price today?
Amrize AG's current stock price is $41.38. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is AMRZ bullish or bearish right now?
AMRZ's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is AMRZ's market cap?
AMRZ's market cap is $23.7B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is AMRZ's current P/E ratio?
AMRZ's current P/E ratio is 29.12 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is AMRZ's RSI?
AMRZ's 14-day RSI is 81.82 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is AMRZ above its 50-day and 200-day moving averages?
AMRZ is 4.58% from its 50-day SMA and -17.80% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is AMRZ's next earnings date?
AMRZ's next earnings date is currently listed as Feb 16, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does AMRZ pay a dividend?
AMRZ's dividend yield is 1.48% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.